Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Perucca, E' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 110 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Perucca, E; Dulac, O; Shorvon, S; Tomson, T
      Harnessing the clinical potential of antiepileptic drug therapy - Dosage optimisation

      CNS DRUGS
    2. French, JA; Perucca, E; Richens, A
      Special issue: Design of clinical trials of antiepileptic drugs - Preface

      EPILEPSY RESEARCH
    3. Perucca, E
      Trial duration and follow-up

      EPILEPSY RESEARCH
    4. Perucca, E
      Discussion: Trials in women

      EPILEPSY RESEARCH
    5. Perucca, E; Richens, A
      Trials in the elderly

      EPILEPSY RESEARCH
    6. Bialer, M; Johannessen, SI; Kupferberg, HJ; Levy, RH; Loiseau, P; Perucca, E
      Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V)

      EPILEPSY RESEARCH
    7. Spina, E; Scordo, MG; Avenoso, A; Perucca, E
      Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    8. Battino, D; Croci, D; Granata, T; Mamoli, D; Messina, S; Perucca, E
      Single-dose pharmacokinetics of lamotrigine in children: Influence of age and antiepileptic comedication

      THERAPEUTIC DRUG MONITORING
    9. Perucca, E
      The management of refractory idiopathic epilepsies

      EPILEPSIA
    10. Genton, P; Guerrini, R; Perucca, E
      Tiagabine in clinical practice

      EPILEPSIA
    11. Spina, E; Avenoso, A; Facciola, G; Salemi, M; Scordo, MG; Ancione, M; Madia, AG; Perucca, E
      Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia

      PSYCHOPHARMACOLOGY
    12. Gatti, G; Furlanut, M; Perucca, E
      Interindividual variability in the metabolism of anti-epileptic drugs and its clinical implications

      INTERINDIVIDUAL VARIABILITY IN HUMAN DRUG METABOLISM
    13. Furlanut, M; Wu, G; Perucca, E
      Variability in the metabolism of levodopa and clinical implications

      INTERINDIVIDUAL VARIABILITY IN HUMAN DRUG METABOLISM
    14. Volosov, A; Bialer, M; Sun, XD; Perucca, E; Sintov, A; Yagen, B
      Simultaneous stereoselective high-performance liquid chromatographic determination of 10-hydroxycarbazepine and its metabolite carbamazepine-10,11-trans-dihydrodiol in human urine

      JOURNAL OF CHROMATOGRAPHY B
    15. Gatti, G; Bonomi, I; Jannuzzi, G; Perucca, E
      The new antiepileptic drugs: Pharmacological and clinical aspects

      CURRENT PHARMACEUTICAL DESIGN
    16. Schmidt, D; Gram, L; Brodie, M; Kramer, G; Perucca, E; Kalviainen, R; Elger, CE
      Tiagabine in the treatment of epilepsy - a clinical review with a guide for the prescribing physician

      EPILEPSY RESEARCH
    17. Perucca, E; Beghi, E; Dulac, O; Shorvon, S; Tomson, T
      Assessing risk to benefit ratio in antiepileptic drug therapy

      EPILEPSY RESEARCH
    18. Parmeggiani, L; Belmonte, A; Ferrari, AR; Perucca, E; Guerrini, R
      Add-on lamotrigine treatment in children and young adults with severe partial epilepsy: An open, prospective, long-term study

      JOURNAL OF CHILD NEUROLOGY
    19. Perucca, E
      Antiepileptic drugs

      SIDE EFFECTS OF DRUGS ANNUAL 23
    20. Perucca, E
      Is there a role for therapeutic drug monitoring of new anticonvulsants?

      CLINICAL PHARMACOKINETICS
    21. Spina, E; Avenoso, A; Facciola, G; Salemi, M; Scordo, MG; Giacobello, T; Madia, AG; Perucca, E
      Plasma concentrations of risperidone and 9-hydroxyrisperidone: Effect of comedication with carbamazepine or valproate

      THERAPEUTIC DRUG MONITORING
    22. Jannuzzi, G; Fattore, C; Gatti, G; Bartoli, A; Perucca, E; Cian, P; Monaco, F
      Untitled - Reply

      EPILEPSIA
    23. Jannuzzi, G; Cian, P; Fattore, C; Gatti, G; Bartoli, A; Monaco, F; Perucca, E
      A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy

      EPILEPSIA
    24. Piccinelli, P; Borgatti, R; Perucca, E; Tofani, A; Donati, G; Balottin, U
      Frontal nonconvulsive status epilepticus associated with high-dose tiagabine therapy in a child with familial bilateral perisylvian polymicrogyria

      EPILEPSIA
    25. Heaney, DC; Shorvon, SD; Sander, JWAS; Boon, P; Komarek, V; Marusic, P; Dravet, C; Perucca, E; Majkowski, J; Lima, JL; Arroyo, S; Tomson, T; Ried, S; van Donselaar, C; Eskazan, E; Peeters, P; Carita, P; Tjong-a-Hung, I; Myon, E; Taieb, C
      Cost minimization analysis of antiepileptic drugs in newly diagnosed epilepsy in 12 European countries

      EPILEPSIA
    26. Spina, E; Avenoso, A; Facciola, G; Scordo, MG; Ancione, M; Madia, AG; Ventimiglia, A; Perucca, E
      Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics

      PSYCHOPHARMACOLOGY
    27. Bialer, M; Johannessen, SI; Kupferberg, HJ; Levy, RH; Loiseau, P; Perucca, E
      Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)

      EPILEPSY RESEARCH
    28. Perucca, E; Tomson, T
      Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications

      EPILEPSY RESEARCH
    29. Guerrini, R; Belmonte, A; Parmeggiani, L; Perucca, E
      Myoclonic status epilepticus following high-dosage lamotrigine therapy

      BRAIN & DEVELOPMENT
    30. Dong, SX; Ring, ZZ; Xiao, WZ; Shu, CC; Fattore, C; Gatti, G; D'Urso, S; Perucca, E
      Possible enhancement of the first-pass metabolism of phenacetin by ingestion of grape juice in Chinese subjects

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    31. Perucca, E
      The spectrum of the new antiepileptic drugs

      ACTA NEUROLOGICA BELGICA
    32. Facciola, G; Avenoso, A; Scordo, MG; Madia, AG; Ventimiglia, A; Perucca, E; Spina, E
      Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders

      THERAPEUTIC DRUG MONITORING
    33. Perucca, E
      Drugs under clinical trial

      ANTIEPILEPTIC DRUGS
    34. Pisani, F; Oteri, G; Russo, MF; Di Perri, R; Perucca, E; Richens, A
      The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: Evidence for a pharmacodynamic interaction

      EPILEPSIA
    35. Fattore, C; Cipolla, G; Gatti, G; Limido, GL; Sturm, Y; Bernasconi, C; Perucca, E
      Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women

      EPILEPSIA
    36. Perucca, E
      The clinical pharmacokinetics of the new antiepileptic drugs

      EPILEPSIA
    37. Volosov, A; Sun, XD; Perucca, E; Yagen, B; Sintov, A; Perucca, E; Yagen, B; Sintov, A; Bialer, M
      Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    38. FATTORE C; CIPOLLA G; GATTI G; BARTOLI A; ORTICELLI G; PICOLLO R; MILLERIOUX L; CIOTTOLI GB; PERUCCA E
      PHARMACOKINETIC INTERACTIONS BETWEEN THEOPHYLLINE AND PRULIFLOXACIN IN HEALTHY-VOLUNTEERS

      Clinical drug investigation
    39. PERUCCA E
      PHARMACORESISTANCE IN EPILEPSY - HOW SHOULD IT BE DEFINED

      CNS drugs
    40. Baldy-Moulinier, M; Covanis, A; D'Urso, S; Eskazan, E; Fattore, C; Gatti, G; Herranz, JL; Ibrahim, S; Khalifa, A; Mrabet, A; Neufeld, MY; Perucca, E
      Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey

      SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
    41. Perucca, E
      Antiepileptic drugs

      SIDE EFFECTS OF DRUGS ANNUAL 21
    42. SPINA E; AVENOSO A; FACCIOLA G; FABRAZZO M; MONTELEONE P; MAJ M; PERUCCA E; CAPUTI AP
      EFFECT OF FLUOXETINE ON THE PLASMA-CONCENTRATIONS OF CLOZAPINE AND ITS MAJOR METABOLITES IN PATIENTS WITH SCHIZOPHRENIA

      International clinical psychopharmacology
    43. FACCIOLA G; AVENOSO A; SPINA E; PERUCCA E
      INDUCING EFFECT OF PHENOBARBITAL ON CLOZAPINE METABOLISM IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA

      Therapeutic drug monitoring
    44. DONG SX; PING ZZ; XIAO WZ; SHU CC; BARTOLI A; GATTI G; DURSO S; PERUCCA E
      EFFECT OF ACTIVE AND PASSIVE CIGARETTE-SMOKING ON CYP1A2-MEDIATED PHENACETIN DISPOSITION IN CHINESE SUBJECTS

      Therapeutic drug monitoring
    45. ZUCCARO P; PACIFICI R; ALTIERI I; AVENOSO A; PELLEGRINI M; SPINA E; PERUCCA E; PICHINI S
      ISSUES IN METHODOLOGY AND APPLICATIONS FOR THERAPEUTIC DRUG-MONITORING OF FLUOXETINE AND NORFLUOXETINE ENANTIOMERS

      Therapeutic drug monitoring
    46. BIALER M; LEVY RH; PERUCCA E
      DOES CARBAMAZEPINE HAVE A NARROW THERAPEUTIC PLASMA-CONCENTRATION RANGE

      Therapeutic drug monitoring
    47. PERUCCA E
      INNOVATIVE MONOTHERAPY TRIAL DESIGNS FOR THE ASSESSMENT OF ANTIEPILEPTIC DRUGS - A CRITICAL-APPRAISAL

      European Journal of Clinical Pharmacology
    48. BAKER GA; CAMFIELD C; CAMFIELD P; CRAMER JA; ELGER CE; JOHNSON AL; DASILVA AM; MEINARDI H; MUNARI C; PERUCCA E; THORBECKE R
      COMMISSION ON OUTCOME MEASUREMENT IN EPILEPSY, 1994-1997 - FINAL REPORT

      Epilepsia
    49. PERUCCA E; GRAM L; AVANZINI G; DULAC O
      ANTIEPILEPTIC DRUGS AS A CAUSE OF WORSENING SEIZURES

      Epilepsia
    50. GUERRINI R; BELMONTE A; CANAPICCHI R; CASALINI C; PERUCCA E
      REVERSIBLE PSEUDOATROPHY OF THE BRAIN AND MENTAL DETERIORATION ASSOCIATED WITH VALPROATE TREATMENT

      Epilepsia
    51. DERIL GM; MORATTI R; PERUCCA E
      TOTAL AND NON-PROTEIN-BOUND FRACTIONS OF 3,4-DIHYDROXYPHENYLALANINE

      Clinical chemistry
    52. PERUCCA E
      A PHARMACOLOGICAL AND CLINICAL REVIEW ON TOPIRAMATE, A NEW ANTIEPILEPTIC DRUG

      Pharmacological research
    53. AVENOSO A; SPINA E; CAMPO G; FACCIOLA G; FERLITO M; ZUCCARO P; PERUCCA E; CAPUTI AP
      INTERACTION BETWEEN FLUOXETINE AND HALOPERIDOL - PHARMACOKINETIC AND CLINICAL IMPLICATIONS

      Pharmacological research
    54. PERUCCA E
      EVALUATION OF DRUG-TREATMENT OUTCOME IN EPILEPSY - A CLINICAL PERSPECTIVE

      Pharmacy world & science
    55. BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
      CONFERENCE REPORT - PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS - A SUMMARY OF THE 3RD EILAT-CONFERENCE (VOL 25, PG 299, 1996)

      Epilepsy research
    56. PERUCCA E; MARCHIONI E; SORAGNA D; SAVOLDI F
      FLUOXETINE-INDUCED MOVEMENT-DISORDERS AND DEFICIENT CYP2D6 ENZYME-ACTIVITY

      Movement disorders
    57. SPINA E; AVENOSO A; CAMPO GM; SCORDO MG; CAPUTI AP; PERUCCA E
      EFFECT OF KETOCONAZOLE ON THE PHARMACOKINETICS OF IMIPRAMINE AND DESIPRAMINE IN HEALTHY-SUBJECTS

      British journal of clinical pharmacology
    58. SPINA E; ARENA D; SCORDO MG; FAZIO A; PISANI F; PERUCCA E
      ELEVATION OF PLASMA CARBAMAZEPINE CONCENTRATIONS BY KETOCONAZOLE IN PATIENTS WITH EPILEPSY

      Therapeutic drug monitoring
    59. BARTOLI A; GUERRINI R; BELMONTE A; ALESSANDRI MG; GATTI G; PERUCCA E
      THE INFLUENCE OF DOSAGE, AGE, AND COMEDICATION ON STEADY-STATE PLASMALAMOTRIGINE CONCENTRATIONS IN EPILEPTIC CHILDREN - A PROSPECTIVE-STUDY WITH PRELIMINARY ASSESSMENT OF CORRELATIONS WITH CLINICAL-RESPONSE

      Therapeutic drug monitoring
    60. SPINA E; GITTO C; AVENOSO A; CAMPO GM; CAPUTI AP; PERUCCA E
      RELATIONSHIP BETWEEN PLASMA DESIPRAMINE LEVELS, CYP2D6 PHENOTYPE AND CLINICAL-RESPONSE TO DESIPRAMINE - A PROSPECTIVE-STUDY

      European Journal of Clinical Pharmacology
    61. BARTOLI A; GATTI G; CIPOLLA G; BARZAGHI N; VELIZ G; FATTORE C; MUMFORD J; PERUCCA E
      A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ON THE EFFECT OF VIGABATRIN ON IN-VIVO PARAMETERS OF HEPATIC-MICROSOMAL ENZYME-INDUCTION AND ON THE KINETICS OF STEROID ORAL-CONTRACEPTIVES IN HEALTHY FEMALE VOLUNTEERS

      Epilepsia
    62. BAREL S; YAGEN B; SCHURIG V; SOBACK S; PISANI F; PERUCCA E; BIALER M
      STEREOSELECTIVE PHARMACOKINETIC ANALYSIS OF VALNOCTAMIDE IN HEALTHY-SUBJECTS AND IN PATIENTS WITH EPILEPSY

      Clinical pharmacology and therapeutics
    63. PERUCCA E
      ESTABLISHED ANTIEPILEPTIC DRUGS

      Bailliere's clinical neurology
    64. BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
      PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS - A SUMMARY OF THE 3RD EILAT CONFERENCE

      Epilepsy research
    65. RIZZO V; MEMMI M; MORATTI R; DERIL GM; PERUCCA E
      CONCENTRATIONS OF L-DOPA IN PLASMA AND PLASMA ULTRAFILTRATES

      Journal of pharmaceutical and biomedical analysis
    66. TARTARA A; SARTORI I; MANNI R; GALIMBERTI CA; DIFAZIO M; PERUCCA E
      EFFICACY AND SAFETY OF TOPIRAMATE IN REFRACTORY EPILEPSY - A LONG-TERM PROSPECTIVE TRIAL

      Italian journal of neurological sciences
    67. SPINA E; PISANI F; PERUCCA E
      CLINICALLY SIGNIFICANT PHARMACOKINETIC DRUG-INTERACTIONS WITH CARBAMAZEPINE - AN UPDATE

      Clinical pharmacokinetics
    68. PERUCCA E; BIALER M
      THE CLINICAL PHARMACOKINETICS OF THE NEWER ANTIEPILEPTIC DRUGS - FOCUS ON TOPIRAMATE, ZONISAMIDE AND TIAGABINE

      Clinical pharmacokinetics
    69. PERUCCA E
      THE NEW-GENERATION OF ANTIEPILEPTIC DRUGS - ADVANTAGES AND DISADVANTAGES

      British journal of clinical pharmacology
    70. BARTOLI A; XIAODONG S; GATTI G; CIPOLLA G; MARCHISELLI R; PERUCCA E
      THE INFLUENCE OF ETHNIC FACTORS AND GENDER ON CYP1A2-MEDIATED DRUG DISPOSITION - A COMPARATIVE-STUDY IN CAUCASIAN AND CHINESE SUBJECTS USING PHENACETIN AS A MARKER SUBSTRATE

      Therapeutic drug monitoring
    71. SPINA E; AVENOSO A; CAMPO GM; CAPUTI AP; PERUCCA E
      PHENOBARBITAL INDUCES THE 2-HYDROXYLATION OF DESIPRAMINE

      Therapeutic drug monitoring
    72. MARCHIONI E; PERUCCA E; SORAGNA D; BO P; MALASPINA A; FERRANDI D; ALBERGATI A; SAVOLDI F
      CHOREIFORM SYNDROME-ASSOCIATED WITH FLUOXETINE TREATMENT IN A PATIENTWITH DEFICIENT CYP2D6 ACTIVITY

      Neurology
    73. MICHELUCCI R; CIPOLLA G; PASSARELLI D; GATTI G; OCHAN M; HEINIG R; TASSINARI CA; PERUCCA E
      REDUCED PLASMA NISOLDIPINE CONCENTRATIONS IN PHENYTOIN-TREATED PATIENTS WITH EPILEPSY

      Epilepsia
    74. PERUCCA E
      PHARMACOKINETIC PROFILE OF TOPIRAMATE IN COMPARISON WITH OTHER NEW ANTIEPILEPTIC DRUGS

      Epilepsia
    75. STABLES JP; BIALER M; JOHANNESSEN SI; KUPFERBERG HJ; LEVY RH; LOISEAU P; PERUCCA E
      PROGRESS REPORT ON NEW ANTIEPILEPTIC DRUGS A SUMMARY OF THE 2ND EILAT-CONFERENCE

      Epilepsy research
    76. PERUCCA E; POITOU P; PIFFERI G
      COMPARATIVE PHARMACOKINETICS AND BIOAVAILABILITY OF 2 ORAL FORMULATIONS OF THIOCOLCHICOSIDE, A GABA-MIMETIC MUSCLE-RELAXANT DRUG, IN NORMALVOLUNTEERS

      European journal of drug metabolism and pharmacokinetics
    77. PIFFERI G; PERUCCA E
      THE COST-BENEFIT RATIO OF ENANTIOMERIC DRUGS

      European journal of drug metabolism and pharmacokinetics
    78. PERUCCA E
      RATIONAL DRUG SELECTION IN ADULTS

      Epilepsia
    79. TARTARA A; SARTORI I; MANNI R; GALIMBERTI CA; DIFAZIO M; PERUCCA E
      ADD-ON TRIAL OF TOPIRAMATE IN REFRACTORY EPILEPSY

      Epilepsia
    80. BARTOLI A; GATTI G; BARZAGHI N; CIPOLLA G; VELIZ G; MUMFORD JP; PERUCCA E
      VIGABATRIN DOES NOT AFFECT IN-VIVO PARAMETERS OF ENZYME-INDUCTION IN HUMANS

      Epilepsia
    81. PERUCCA E
      SHOULD WIDESPREAD COMPASSIONATE USE BEFORE REGISTRATION BE ALLOWED - A CONTRARY VIEW

      Epilepsia
    82. PISANI F; OTERI G; RUSSO M; TRIO R; DIPERRI R; PERUCCA E; RICHENS A
      EFFECTS OF LAMOTRIGINE-VALPROATE COMEDICATION ON SEIZURE FREQUENCY AND UPPER-LIMB TREMOR - A PHARMACODYNAMIC INTERACTION

      Epilepsia
    83. BEGHI E; PERUCCA E
      THE MANAGEMENT OF EPILEPSY IN THE 1990S - ACQUISITIONS, UNCERTAINTIESAND PRIORITIES FOR FUTURE-RESEARCH

      Drugs
    84. PERUCCA E
      PHARMACOLOGICAL PRINCIPLES AS A BASIS FOR POLYTHERAPY

      Acta neurologica Scandinavica
    85. SILFVENIUS H; HALASZ P; ROSCISZEWSKA; HAUSER WA; STELMASIAK; SCHMIDT D; PITKANEN A; MATTSON RH; MARROSU; RICHENS A; PERUCCA E; YLINEN A; DEBITTENCOURT PRM
      THE RATIONAL MANAGEMENT OF EPILEPSY THROUGH GREATER UNDERSTANDING OF THE DISEASE - DISCUSSION

      Acta neurologica Scandinavica
    86. SPINA E; AVENOSO A; CAMPO GM; CAPUTI AP; PERUCCA E
      THE EFFECT OF CARBAMAZEPINE ON THE 2-HYDROXYLATION OF DESIPRAMINE

      Psychopharmacology
    87. SPINA E; PERUCCA E
      NEWER AND OLDER ANTIDEPRESSANTS - A COMPARATIVE REVIEW OF DRUG-INTERACTIONS

      CNS DRUGS
    88. SPINA E; CAMPO GM; AVENOSO A; CAPUTI AP; ZUCCARO P; PACIFICI R; GATTI G; STRADA G; BARTOLI A; PERUCCA E
      CYP2D6-RELATED OXIDATION POLYMORPHISM IN ITALY

      Pharmacological research
    89. GATTI G; PERUCCA E
      PLASMA-CONCENTRATIONS OF FREE AND CONJUGATED SILYBIN AFTER ORAL INTAKE OF A SILYBIN-PHOSPHATIDYLCHOLINE COMPLEX (SILIPIDE) IN HEALTHY-VOLUNTEERS

      International journal of clinical pharmacology and therapeutics
    90. PISANI F; XIAO B; FAZIO A; SPINA E; PERUCCA E; TOMSON T
      SINGLE-DOSE PHARMACOKINETICS OF CARBAMAZEPINE-10,11-EPOXIDE IN PATIENTS ON LAMOTRIGINE MONOTHERAPY

      Epilepsy research
    91. CORASANITI MT; GATTI G; CREMA F; ATTARDOPARRINELLO G; BARZAGHI N; PERUCCA E
      THE DISPOSITION OF THEOPHYLLINE IN PATIENTS WITH LUNG AND BREAST-CANCER

      Drugs under experimental and clinical research
    92. SCHANDALIK R; PERUCCA E
      PHARMACOKINETICS OF SILYBIN FOLLOWING ORAL-ADMINISTRATION OF SILIPIDEIN PATIENTS WITH EXTRAHEPATIC BILIARY OBSTRUCTION

      Drugs under experimental and clinical research
    93. PERUCCA E; GATTI G; SPINA E
      CLINICAL PHARMACOKINETICS OF FLUVOXAMINE

      Clinical pharmacokinetics
    94. SPINA E; AVENOSO A; CAMPO GM; CAPUTI AP; PERUCCA E
      DECREASED PLASMA-CONCENTRATIONS OF IMIPRAMINE AND DESIPRAMINE FOLLOWING CHOLESTYRAMINE INTAKE IN DEPRESSED-PATIENTS

      Therapeutic drug monitoring
    95. XIAODONG S; GATTI G; BARTOLI A; CIPOLLA G; CREMA F; PERUCCA E
      OMEPRAZOLE DOES NOT ENHANCE THE METABOLISM OF PHENACETIN, A MARKER OFCYP1A2 ACTIVITY, IN HEALTHY-VOLUNTEERS

      Therapeutic drug monitoring
    96. GATTI G; BARTOLI A; BERTIN D; STROLINBENEDETTI M; PERUCCA E
      PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOLLOWING SINGLE AND MULTIPLE DOSES OF ROLAFAGREL, A NOVEL INHIBITOR OF THROMBOXANE SYNTHASE, IN NORMAL VOLUNTEERS

      European Journal of Clinical Pharmacology
    97. GATTI G; BARTOLI A; BERTIN D; STROLINBENEDETTI M; PERUCCA E
      PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES FOLLOWING SINGLE AND MULTIPLE DOSES OF ROLAFAGREL, A NOVEL INHIBITOR OF THROMBOXANE SYNTHASE, IN NORMAL VOLUNTEERS

      European Journal of Clinical Pharmacology
    98. ADAMOLEKUM B; CARPIO A; CARVALHO P; GARCIAPEDROSA F; MAHESHWARI MC; MEINARDI H; ORDINARIO A; OSUNTOKUM B; PERUCCA E; PRICE RW; ROMAN G; SHAKIR RA; SOTELO J; SPINAFRANCA A; TAKAYANAGUI O; DEBITTENCOURT PRM; BHARUCHA N
      RELATIONSHIP BETWEEN EPILEPSY AND TROPICAL DISEASES

      Epilepsia
    99. PERUCCA E; GATTI G; CIPOLLA G; SPINA E; BAREL S; SOBACK S; GIPS M; BIALER M
      INHIBITION OF DIAZEPAM METABOLISM BY FLUVOXAMINE - A PHARMACOKINETIC STUDY IN NORMAL VOLUNTEERS

      Clinical pharmacology and therapeutics
    100. PISANI F; FAZIO A; OTERI G; ARTESI C; XIAO B; PERUCCA E; DIPERRI R
      EFFECTS OF THE ANTIDEPRESSANT DRUG VILOXAZINE ON OXCARBAZEPINE AND ITS HYDROXYLATED METABOLITES IN PATIENTS WITH EPILEPSY

      Acta neurologica Scandinavica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 15:08:33